Timothy Squire is one of Canada's leading Life Sciences Industry Specialists. With over 23 years of experience, Tim has become a trusted advisor to stakeholders in the drug, medical device, natural health product, cosmetic and food industries in Canada and from around the world. He is widely recognized for his commitment to exceptional client service and his expertise across the entire health product lifecycle. Tim's life sciences regulatory practice covers all aspects of health product regulation, and he is one of the few specialists in Canada regularly called upon to help solve complex market access, compliance and enforcement issues. Tim frequently communicates with Health Canada and other federal and provincial agencies on his clients’ behalf, assists with the design and implementation of comprehensive regulatory compliance strategies, and has been instrumental in the successful launch of many new drugs, medical devices and other regulated health products in Canada. In addition to his regulatory expertise, Tim also negotiates and drafts sophisticated commercial agreements for life sciences clients, including license, distribution, manufacturing, importation, wholesale, supply, quality, pharmacovigilance, product listing, material transfer, joint R&D, funding, clinical trial, vendor and consultant agreements.Tim frequently quarterbacks regulatory due diligence in complex domestic and cross-border transactions involving drug, medical device, natural health product, cosmetic, and food companies, and is often called upon to manage post-closing integration, including the transition of market authorizations, and regulatory and compliance operations.Tim performs in-house legal and compliance functions for several U.S. and international life sciences clients without Canadian in-house legal or regulatory capabilities, and in this capacity has developed a comprehensive understanding of the business issues and pressures facing companies in the life sciences industry.Tim’s expertise in the life sciences sector has been recognized by Chambers Canada, Who’s Who Legal, Lexpert, IAM Strategy 300, and he has received LMG’s Life Sciences Canadian Regulatory Attorney of the Year award three times, most recently in 2020.